跳至主要内容
临床试验/NCT06973278
NCT06973278招募中不适用

A Prospective Study on Clinical Effectiveness After SMILE Versus SMILE Xtra in Myopia

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
visual acuity

研究概览

简要总结

To evaluate the clinical efficacy and refractive stability of SMILE Xtra compared to SMILE in patients with myopia

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 and 50 years.
  • High myopia with a manifest refraction spherical equivalent (MRSE) - 6.00D~-10.00D and refractive changes within ± 0.50D in the past two years;
  • Best corrected distance visual acuity (CDVA) ≥ 20/
  • Preoperative refractive status is stable (myopia progression not exceeding 0.50D per year for at least 2 years).
  • Predicted residual stromal thickness (RST) ≥ 250μm after lenticule removal. 6.Soft contact lenses discontinued for at least 1 week, rigid contact lenses for at least 3 weeks, and orthokeratology lenses for at least 3 months.

排除标准

  • The presence of other eye diseases: keratoconus or suspected keratoconus, active keratoconjunctivitis, severe dry eye, glaucoma, retinal diseases such as retinal tears or macular degeneration, etc.,
  • The presence of significant corneal scarring or cataracts affects observation.
  • Systemic diseases such as active systemic inflammation, connective tissue diseases, other conditions that prevent

结局指标

主要结局

visual acuity

时间窗: 1 week, 1 month, 6 months, 12 months,24 months and 36 months

次要结局

未报告次要终点

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验